Intech Investment Management LLC Makes New $120,000 Investment in SIGA Technologies, Inc. (NASDAQ:SIGA)

Intech Investment Management LLC acquired a new position in shares of SIGA Technologies, Inc. (NASDAQ:SIGA) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 17,819 shares of the company’s stock, valued at approximately $120,000.

Other large investors have also recently added to or reduced their stakes in the company. DekaBank Deutsche Girozentrale bought a new position in SIGA Technologies during the 2nd quarter worth $40,000. China Universal Asset Management Co. Ltd. increased its position in SIGA Technologies by 64.3% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock worth $93,000 after buying an additional 5,372 shares during the period. AQR Capital Management LLC bought a new position in SIGA Technologies during the 2nd quarter worth $99,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in SIGA Technologies by 38.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,684 shares of the company’s stock worth $104,000 after buying an additional 3,829 shares during the period. Finally, SG Americas Securities LLC acquired a new stake in shares of SIGA Technologies during the 3rd quarter worth $143,000. Institutional investors own 55.40% of the company’s stock.

SIGA Technologies Stock Performance

SIGA opened at $6.96 on Friday. The firm has a market cap of $496.94 million, a P/E ratio of 5.80 and a beta of 0.89. SIGA Technologies, Inc. has a 52-week low of $4.26 and a 52-week high of $12.83. The business’s fifty day moving average is $6.88 and its 200-day moving average is $7.81.

SIGA Technologies (NASDAQ:SIGA) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.02 EPS for the quarter. The firm had revenue of $10.01 million during the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. On average, research analysts predict that SIGA Technologies, Inc. will post 1.04 earnings per share for the current fiscal year.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.